XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Supplemental Balance Sheet Information (Tables)
3 Months Ended
Mar. 31, 2023
Supplemental Financial Statement Information [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash

The reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet to the totals shown within the condensed consolidated statement of cash flows is as follows (in thousands):

 

 

As of March 31,

 

 

2023

 

 

2022

 

Cash and cash equivalents

 

$

1,206,086

 

 

$

1,492,971

 

Restricted cash included in prepaid expenses and other current assets (1)

 

 

8,149

 

 

 

2,197

 

Restricted cash included in other non-current assets (1)

 

 

44,433

 

 

 

40,677

 

Total cash, cash equivalents and restricted cash

 

$

1,258,668

 

 

$

1,535,845

 

Schedule of Inventory, Net

Inventory, net consisted of the following (in thousands):

 

As of March 31,

 

 

As of December 31,

 

 

2023

 

 

2022

 

Finished goods

 

$

5,296

 

 

$

6,556

 

Raw materials

 

 

2,259

 

 

 

1,590

 

Less: Inventory reserve

 

 

(5,046

)

 

 

(3,782

)

Inventory, net

 

$

2,509

 

 

$

4,364

 

Summary of Property and Equipment Net

Property, plant, and equipment, net consisted of the following (in thousands):

 

As of March 31,

 

 

As of December 31,

 

 

2023

 

 

2022

 

Buildings and facilities

 

$

46,505

 

 

$

46,019

 

Furniture and fixtures

 

 

8,355

 

 

 

8,206

 

Lab equipment

 

 

194,242

 

 

 

183,292

 

Computer equipment and software

 

 

15,097

 

 

 

15,219

 

Leasehold improvements

 

 

130,590

 

 

 

125,307

 

Construction in progress

 

 

20,384

 

 

 

23,426

 

Land

 

 

6,060

 

 

 

6,060

 

Total property, plant, and equipment

 

 

421,233

 

 

 

407,529

 

Less: Accumulated depreciation and amortization

 

 

(107,260

)

 

 

(92,756

)

Property, plant, and equipment, net

 

$

313,973

 

 

$

314,773

 

 

Schedule of Capitalization

The following table presents the Company’s authorized, issued, and outstanding common stock as of the dates indicated (in thousands):

 

Authorized

 

 

Issued

 

 

Outstanding

 

Common stock as of March 31, 2023:

 

 

 

 

 

 

 

 

Class A

 

10,500,000

 

 

 

1,572,669

 

 

 

1,458,237

 

Class B

 

4,500,000

 

 

 

380,387

 

 

 

355,643

 

Class C

 

800,000

 

 

 

120,000

 

 

 

120,000

 

 

 

15,800,000

 

 

 

2,073,056

 

 

 

1,933,880

 

Common stock as of December 31, 2022:

 

 

 

 

 

 

 

 

Class A

 

10,500,000

 

 

 

1,448,234

 

 

 

1,337,499

 

Class B

 

4,500,000

 

 

 

383,649

 

 

 

354,477

 

Class C

 

800,000

 

 

 

200,000

 

 

 

200,000

 

 

 

15,800,000

 

 

 

2,031,883

 

 

 

1,891,976